AXIM Biotechnologies, Inc.
AXIM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $606 | $4,326 | $4,583 | $56,957 |
| - Cash | $0 | $156 | $47 | $453 |
| + Debt | $6,641 | $5,895 | $5,665 | $6,719 |
| Enterprise Value | $7,246 | $10,064 | $10,201 | $63,223 |
| Revenue | $70 | $40 | $9 | $60 |
| % Growth | 78.3% | 345.3% | -85.3% | – |
| Gross Profit | -$369 | $40 | -$417 | $60 |
| % Margin | -524.1% | 100% | -4,701.4% | 100% |
| EBITDA | -$2,444 | -$6,428 | -$3,940 | -$13,165 |
| % Margin | -3,468.6% | -16,265.7% | -44,398.9% | -21,775.3% |
| Net Income | -$3,512 | -$8,060 | -$5,957 | -$16,518 |
| % Margin | -4,985.2% | -20,395% | -67,120.7% | -27,320.8% |
| EPS Diluted | -0.011 | -0.035 | -0.036 | -0.13 |
| % Growth | 68.9% | 1.7% | 72.3% | – |
| Operating Cash Flow | -$855 | -$1,031 | -$2,044 | -$2,487 |
| Capital Expenditures | -$3 | $0 | -$9 | -$50 |
| Free Cash Flow | -$858 | -$1,031 | -$2,053 | -$2,537 |